Khan, M. A.

Authored

(299f) Quality-by-Design (QbD): Integration of Real-Time PAT Process Monitoring and off-Line Product Characterization to Explore the Linkage Between a Pharmaceutical Process and Product

2010 Annual Meeting

(111e) Quality-by-Design (QbD): Process Trajectory Development for a Pharmaceutical Co-Precipitation Process Based On An Integrated Real-Time Process Monitoring Strategy

2009 Annual Meeting

(585e) Quality-by-Design (QbD): Examining the Impact of Process Variables On Particle Size Distribution for a Pharmaceutical Co-Precipitation Process Using Real-Time Lasentec FBRM and PVM Process Monitoring and Design of Experiments (DoE) Approach

2009 Annual Meeting

(325b) The FDA – Novartis CRADA: A Risk-Based and Systems Approach for Quality by Design (QbD) Implementation for An Approved Pharmaceutical Product

2009 Annual Meeting

(252a) Pharmaceutical Coating Operations: Challenges and Opportunities in the Changing Regulatory Paradigm

2005 Annual Meeting

(585c) Application of Quality by Design Principles to Development of Freeze-Dried Parenteral Dosage Forms

2009 Annual Meeting

Related Proceedings

2005 Annual Meeting 2009 Annual Meeting 2010 Annual Meeting